Trial Profile
Alogriptin versus Standard Therapy on Diastolic Dysfunction in Type2 Diabetes Mellitus-Juntendo
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 25 Dec 2015
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms ADAM-J
- 13 Dec 2015 Status changed from recruiting to discontinued, according to University Hospital Medical Information Network - Japan record.
- 19 Jun 2012 New trial record